3. Melatonin‐micronutrients Osteopenia Treatment Study (MOTS): a translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopenic women following a one‐year double‐blind RCT and on osteoblast‐osteoclast co‐cultures
Maria S, Swanson M, Enderby L, et al. AGING. 2017.
In postmenopausal osteopenic women, supplementation with melatonin, strontium, vitamin D3 and vitamin K2 increased bone mineral density, reduced bone turnover and improved sleep quality, compared to placebo, over the course of a year.